1. Home
  2. CBLL vs HELP Comparison

CBLL vs HELP Comparison

Compare CBLL & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CeriBell Inc.

CBLL

CeriBell Inc.

N/A

Current Price

$27.56

Market Cap

935.3M

Sector

N/A

ML Signal

N/A

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

N/A

Current Price

$9.45

Market Cap

862.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CBLL
HELP
Founded
2014
2019
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
935.3M
862.2M
IPO Year
2024
2020

Fundamental Metrics

Financial Performance
Metric
CBLL
HELP
Price
$27.56
$9.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
11
Target Price
$31.57
★ $41.56
AVG Volume (30 Days)
647.2K
★ 1.5M
Earning Date
11-03-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 56.93
N/A
EPS
N/A
★ N/A
Revenue
★ $89,063,000.00
N/A
Revenue This Year
$29.72
N/A
Revenue Next Year
$27.43
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 36.09
N/A
52 Week Low
$11.75
$3.76
52 Week High
$28.89
$15.15

Technical Indicators

Market Signals
Indicator
CBLL
HELP
Relative Strength Index (RSI) 56.29 41.61
Support Level $22.96 $4.41
Resistance Level $28.11 $11.74
Average True Range (ATR) 1.67 0.90
MACD -0.11 -0.10
Stochastic Oscillator 81.38 33.53

Price Performance

Historical Comparison
CBLL
HELP

About CBLL CeriBell Inc.

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: